2026-01-26 - Analysis Report
**1. Company Overview**

DuPont de Nemours is a multinational specialty materials company.

**2. Return Rate Comparison**

- Cumulative Return (Review Stock): 61.24%
- Cumulative Return (S&P 500, VOO): 126.41%
- Divergence: -66.30 (-max 16.90, min -106.30, relative divergence: 32.50%)

The review stock underperformed the S&P 500, resulting in a divergence of -66.30.

**3. Alpha and Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|------|------|-------|
| 2016-2018 | -5.0% | 24.7% | -18.0% | 1.1 | 13.3B |
| 2017-2019 | -37.0% | 24.7% | -63.0% | 1.2 | 11.2B |
| 2018-2020 | -33.0% | 56.2% | -57.0% | 1.2 | 12.5B |
| 2019-2021 | 23.0% | 56.2% | -43.0% | 1.1 | 14.2B |
| 2020-2022 | 37.0% | 45.0% | 30.0% | 1.1 | 12.0B |
| 2021-2023 | 0.0% | 32.7% | -21.0% | 1.1 | 13.5B |
| 2022-2024 | 4.0% | 31.3% | -26.0% | 1.0 | 13.4B |
| 2023-2025 | 36.0% | 34.6% | -39.0% | 1.1 | 16.8B |

The alpha was generally negative, while the beta remained relatively stable (1.0-1.2). Market capitalization declined significantly in the 2017-2019 period before rebounding.

**4. Recent Stock Price Fluctuations**

- Close: $44.14
- Last-Market: {'price': 44.14, 'previousClose': 43.79, 'change': 0.8}
- 5-day SMA: $43.29
- 20-day SMA: $42.54
- 60-day SMA: $40.30

The stock price has been increasing, but its short-term moving average is still below the long-term average.

**5. RSI, PPO, and Expected Return**

- Market Risk Indicator (MRI): 0.70
- RSI: 69.30
- PPO: -0.05
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.70)
- Recent (20 days) relative divergence change: improving (+3.00)
- 7-day Rank change: flat (0)
- 7-day Dynamic Expected Return change: flat (0.00)

The RSI is above 60, indicating an overbought condition. The PPO is negative, indicating a long-term downtrend. The expected return is -121.80%, a very negative value.

**6. Recent News & Significant Events**

* 2026-01-22: [Is DuPont de Nemours (DD) Fairly Priced After 36% One Year Share Price Gain?](link)
* 2026-01-22: [DuPont de Nemours Inc (DD) Stock Price Up 3.46% on Jan 22](link)
* 2026-01-24: [What DuPont de Nemours (DD)'s Board Addition of D.G. Macpherson Means For Shareholders](link)
* 2026-01-23: [DuPont de Nemours (DD) Receives Outperform Rating From RBC Capital](link)
* 2026-01-08: [DuPont Slashes Dividend, And That Might Be Their Best Move For Sustainable Growth](link)
* 2026-01-21: [DuPont to detail 2025 results in Feb. 10 earnings call](link)

Recent news suggests a mixed sentiment, ranging from price gains to dividend cuts and board additions.

**7. Analyst Opinions**

Analyst Consensus:
- Key: Strong_Buy
- Mean (1=StrongBuy~5=Sell): 1.47 (~Strong Buy)
- Opinions: 16
- Target Price (avg/high/low): 49.19 / 56.00 / 44.00

Analysts are generally optimistic about the stock, with a mean rating of Strong Buy.

**8. Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-07 | 0.1 | 0.89 B$ |
| 2025-08-08 | 0.01 | 0.83 B$ |
| 2025-05-07 | 0.07 | 0.76 B$ |
| 2024-11-08 | 0.15 | 0.69 B$ |
| 2025-11-07 | 0.15 | 0.69 B$ |

Earnings per share (EPS) have been relatively stable, while revenue has increased slightly.

**9. Quarterly Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $3.07B | 38.90% |
| 2025-06-30 | $3.26B | 37.33% |
| 2025-03-31 | $3.07B | 37.38% |
| 2024-12-31 | $3.09B | 36.38% |
| 2024-09-30 | $2.86B | 39.24% |

Profit margin has generally decreased over the past two years, but revenue has increased.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $22.89B | -0.54% |
| 2025-06-30 | $23.06B | 0.26% |
| 2025-03-31 | $22.83B | -2.58% |
| 2024-12-31 | $23.35B | -0.51% |
| 2024-09-30 | $24.21B | 1.88% |

Equity has increased, but return on equity (ROE) has been negative for most of the past two years.

**10. Comprehensive Analysis**

The stock has underperformed the S&P 500, resulting in a significant divergence. The alpha has generally been negative, and market capitalization has declined in the 2017-2019 period. The RSI is above 60, indicating an overbought condition, and the PPO is negative, indicating a long-term downtrend. The expected return is -121.80%, a very negative value. Recent news suggests a mixed sentiment. Analysts are generally optimistic about the stock, but earnings have been relatively stable, and revenue has increased slightly.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.